NINE MONTHS RESULTS
Indoco Remedies Ltd.
BSE
Jul 09, 01:25
327.65
+1.90 (+ 0.58%)
Volume
1741
Prev. Close
325.75
Open Price
318.55
Bid Price(Qty.)
327.40 (1)
Offer Pr.(Qty.)
328.50 (1)
NSE
Jul 09, 01:14
329.15
+4.00 (+ 1.23%)
Volume
29228
Prev. Close
325.15
Open Price
321.90
Bid Price(Qty.)
328.40 (1)
Offer Pr.(Qty.)
329.10 (1)
You can view the
Nine Months Results
for the last 5 years.
ISIN No
|
INE873D01024
|
Market Cap. ( ₹ in Cr. )
|
3036.34
|
P/BV
|
2.79
|
Book Value ( ₹ )
|
118.11
|
BSE Code
|
532612
|
52 Week High/Low ( ₹ )
|
388/190
|
FV/ML
|
2/1
|
P/E(X)
|
0.00
|
NSE Code
|
INDOCOEQ
|
Book Closure
|
26/09/2024
|
EPS ( ₹ )
|
0.00
|
Div Yield (%)
|
0.06
|
(₹ in Crs.)
Net Sales/Income from operations | 1170.94 | 1345.32 | 1239.23 | 1130.84 | 922.57 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 12.88 |
Total Income From Operations | 1170.94 | 1345.32 | 1239.23 | 1130.84 | 935.45 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 262.57 | 337.62 | 319.62 | 262.21 | 224.21 |
Purchase of Traded Goods | 110.31 | 88.49 | 65.27 | 83.55 | 49.09 |
Increase/Decrease in Stocks | -19.06 | -21.08 | 4.94 | -20.49 | -7.12 |
Employees Cost | 268.80 | 267.68 | 244.77 | 219.53 | 212.95 |
Depreciation | 73.37 | 64.25 | 52.91 | 60.91 | 54.58 |
ResearchAndDevlopmentExpenses | 0.00 | 0.00 | 0.00 | 0.00 | 43.28 |
Other Expenses | 423.74 | 471.99 | 383.91 | 339.51 | 244.04 |
Total Expenses | 1119.73 | 1208.95 | 1071.42 | 945.22 | 821.03 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 51.21 | 136.37 | 167.81 | 185.62 | 114.42 |
Other Income | 11.98 | 4.46 | 1.84 | 2.03 | 1.15 |
P/L Before Interest, Excpt. Items & Tax | 63.19 | 140.83 | 169.65 | 187.65 | 115.57 |
Interest | 40.65 | 25.91 | 16.39 | 11.10 | 17.67 |
P/L Before Exceptional Items & Tax | 22.54 | 114.92 | 153.26 | 176.55 | 97.90 |
Exceptional Items | 0.99 | -8.20 | 0.00 | 0.00 | 0.00 |
P/L Before Tax | 23.53 | 106.72 | 153.26 | 176.55 | 97.90 |
Tax | 6.02 | 27.64 | 37.27 | 62.40 | 30.42 |
P/L After Tax from Ordinary Activities | 17.51 | 79.08 | 115.99 | 114.15 | 67.48 |
Net Profit/Loss For the Period | 17.51 | 79.08 | 115.99 | 114.15 | 67.48 |
| | | | | |
Equity Share Capital | 18.44 | 18.43 | 18.43 | 18.43 | 18.43 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 1.90 | 8.58 | 12.59 | 12.39 | 7.32 |
Diluted EPS (Rs.) | 1.90 | 8.57 | 12.59 | 12.39 | 7.32 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 1.90 | 8.58 | 12.59 | 12.39 | 7.32 |
Diluted EPS (Rs.) | 1.90 | 8.57 | 12.59 | 12.39 | 7.32 |
| | | | | |
PBITOE Margin (%) | 4.37 | 10.13 | 13.54 | 16.41 | 12.23 |
PBTE Margin (%) | 1.92 | 8.54 | 12.36 | 15.61 | 10.46 |
PBT Margin (%) | 2.00 | 7.93 | 12.36 | 15.61 | 10.46 |
PAT Margin (%) | 1.49 | 5.87 | 9.35 | 10.09 | 7.21 |